Protagonist Therapeutics Inc
PTGX
Market Cap$3.16B
Close$
$1.33
97.4% downside
Current Fair Value
97.4% downsideOvervalued by 97.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.16 Billion |
|---|---|
| Enterprise Value | $3.05 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $4.47 |
| Beta | 2.25 |
| Outstanding Shares | 62,963,806 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 57.2 |
|---|---|
| PEG | -54.16 |
| Price to Sales | 17.02 |
| Price to Book Ratio | 5.11 |
| Enterprise Value to Revenue | 14.7 |
| Enterprise Value to EBIT | 112.49 |
| Enterprise Value to Net Income | 54 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data